Researchers at Johns Hopkins University have used nanoparticles to test the mucus of patients with chronic obstructive pulmonary disease (COPD). The researchers hope that their approach will allow for early detection of COPD progression and will therefore help clinicians to deliver therapies in a more timely manner.
An official website of the United States government.